Figure 1From: Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapyId1 and Id3 immunohistochemistry in non-small cell lung cancer samples. Id1 expression (20×) with final H-score of 9 (A) and Id3 expression (20×) with final H-score of 6 (B). Lack of Id1 (20×) (C) and Id3 (20×) (D) expression with final H-score of 0.Back to article page